Prior to joining PrecisionMed, Inc. as its President and founder, Dr. Flax worked in the pharmaceutical industry in both the United States and United Kingdom.

Dr. Flax has 15 years experience in clinical drug development as director of cardiovascular development at Pfizer, Warner Lambert and Beecham (UK).

His experience includes designing and managing clinical research programs as well as extensive FDA experience including prosecuting new drug applications.

Dr. Flax, while maintaining his position at PrecisionMed, has consulted for numerous US and European pharmaceutical companies and has represented them at FDA.

Apart from the development of FDA submissions and regular FDA interactions, Dr. Flax has conducted several successful FDA Advisory committee meetings.

Dr. Flax was trained in cardiology at St. Mary’s Hospital in London, UK, and holds a MB, ChB from the University of Cape Town, South Africa and membership of the Royal College of Physicians of the United Kingdom (MRCP(UK)).